Abbott’s Next-Generation Spinal Cord Stimulator Gets FDA Nod
Executive Summary
The newly approved Proclaim Plus system allows physicians to treat as many as six independent pain sites and choose the lowest-possible effective dose for each site.
You may also be interested in...
Abbott Launches NeuroSphere Virtual Clinic For Remote Neurostim Programming
The US FDA approved Abbott's system that allows physicians to communicate with patients and remotely program their neuromodulation device.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.
Behavioral Health Company Two Chairs Secures $72M In Equity And Debt Infusion
Two Chairs, which uses algorithms to match the right therapists with patients, secured $72m in investment to expand its business.